AHA, ACC Issue First CKM Syndrome Guideline, Replacing 2013 Obesity Care Standard
Updated
Updated · American College of Cardiology · Jun 8
AHA, ACC Issue First CKM Syndrome Guideline, Replacing 2013 Obesity Care Standard
3 articles · Updated · American College of Cardiology · Jun 8
Summary
2026 guidance from the AHA and ACC, developed with diabetes and nephrology groups, sets the first unified standard for cardiovascular-kidney-metabolic syndrome and frames the condition in four stages.
New recommendations push earlier screening and prevention, using PREVENT equations to estimate 10- and 30-year cardiovascular risk with kidney and metabolic factors included.
For treatment, the guideline spans lifestyle changes, medications and bariatric or metabolic surgery, and for the first time recommends GLP-1-based therapies for some patients with obesity or type 2 diabetes plus added cardiovascular risk.
Kidney assessment now emphasizes both eGFR and urine albumin-to-creatinine ratio to classify chronic kidney disease and guide kidney-protective therapy with cardiovascular benefit.
The document retires and expands the 2013 adult overweight and obesity guideline, while authors say evidence gaps remain for patients with heart failure, advanced CKD and both conditions together.
Can a simple Cardiometabolic Index from China be a better CKM risk predictor than our complex new equations?
As new CKM drugs emerge, how can we prevent a two-tiered system where only the wealthy can afford them?
Is the new CKM syndrome a public health breakthrough or the over-medicalization of nearly every adult?
Transforming Care in 2026: The First Unified Clinical Guideline for Cardiovascular-Kidney-Metabolic Syndrome
Overview
On June 9, 2026, four leading medical organizations released the first-ever clinical guideline for Cardiovascular-Kidney-Metabolic (CKM) syndrome. This landmark guideline marks a major step toward integrated patient care by providing a unified, evidence-based framework to address the complex interplay of metabolic risk factors like obesity and diabetes, chronic kidney disease, and cardiovascular disease. CKM syndrome, defined by these interconnected conditions, greatly increases the risk of serious health outcomes such as kidney failure, heart attack, and stroke. The growing burden of CKM syndrome highlights the urgent need for this coordinated approach.